42 related articles for article (PubMed ID: 8748808)
1. A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Reardon DA; Zalutsky MR; Akabani G; Coleman RE; Friedman AH; Herndon JE; McLendon RE; Pegram CN; Quinn JA; Rich JN; Vredenburgh JJ; Desjardins A; Guruangan S; Boulton S; Raynor RH; Dowell JM; Wong TZ; Zhao XG; Friedman HS; Bigner DD
Neuro Oncol; 2008 Apr; 10(2):182-9. PubMed ID: 18287339
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.
Zalutsky MR; Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Wong TZ; Bigner DD
J Nucl Med; 2008 Jan; 49(1):30-8. PubMed ID: 18077533
[TBL] [Abstract][Full Text] [Related]
3. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
Goetz CM; Rachinger W; Decker M; Gildehaus FJ; Stocker S; Jung G; Tatsch K; Tonn JC; Reulen HJ
Cancer Immunol Immunother; 2005 Apr; 54(4):337-44. PubMed ID: 15449040
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral administration of IL2- and TNF-based fusion proteins cures cancer without establishing protective immunity.
Ziffels B; Pretto F; Neri D
Immunotherapy; 2018 Mar; 10(3):177-188. PubMed ID: 29370721
[TBL] [Abstract][Full Text] [Related]
5. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.
Boswell CA; Brechbiel MW
Nucl Med Biol; 2007 Oct; 34(7):757-78. PubMed ID: 17921028
[TBL] [Abstract][Full Text] [Related]
6. Photon radiotherapy for the treatment of high-grade gliomas.
Hwang CS; Marymont MH; Muro K
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S37-43. PubMed ID: 18076317
[TBL] [Abstract][Full Text] [Related]
7. Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas.
Arista A; Sturiale C; Riva P; Tison V; Frattarelli M; Moscatelli G; Franceschi G; Spinelli A
Acta Neurochir (Wien); 1995; 135(3-4):159-62. PubMed ID: 8748808
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
9. Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2.
Riva P; Arista A; Sturiale C; Moscatelli G; Tison V; Mariani M; Seccamani E; Lazzari S; Fagioli L; Franceschi G
Int J Cancer; 1992 Apr; 51(1):7-13. PubMed ID: 1373410
[TBL] [Abstract][Full Text] [Related]
10. The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain.
Miyamoto CT; Brady LW; Rackover MA; Emrich J; Class R; Bender H; Micaily B; Steplewski Z
Recent Results Cancer Res; 1996; 141():183-92. PubMed ID: 8722428
[No Abstract] [Full Text] [Related]
11. Malignant transformation of benign gliomas during interstitial irradiation.
Hellwig D; Mennel HD; Bauer BL; List-Hellwig E; Koop EA; Neidel HO
Acta Neurochir Suppl; 1995; 63():101-8. PubMed ID: 7502718
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas.
Quang TS; Brady LW
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):972-5. PubMed ID: 14967458
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
Walker MD; Green SB; Byar DP; Alexander E; Batzdorf U; Brooks WH; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Owens G; Ransohoff J; Robertson JT; Shapiro WR; Smith KR; Wilson CB; Strike TA
N Engl J Med; 1980 Dec; 303(23):1323-9. PubMed ID: 7001230
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.
Bourdon MA; Coleman RE; Blasberg RG; Groothuis DR; Bigner DD
Anticancer Res; 1984; 4(3):133-40. PubMed ID: 6465851
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]